Contact
Please use this form to send email to PR contact of this press release:
Cellceutix Receives FDA Orphan Drug Designation for Kevetrin for the Treatment of Retinoblastoma
TO:
Please use this form to send email to PR contact of this press release:
Cellceutix Receives FDA Orphan Drug Designation for Kevetrin for the Treatment of Retinoblastoma
TO: